CONFERENCES
CURRENT PROJECTS (UP TO DATE)
LINKS
CONTACT
PÁGINA PRINCIPAL DE ANIRIDIA
WHAT IS ANIRIDIA?
THE ASSOCIATION
PUBLICATIONS
SECTION ITEM
apartado_izq.jpg (936 bytes)   apartado_der.jpg (989 bytes)
apartado_bajo.jpg (2159 bytes)
esq1.jpg (734 bytes)

UP TO DATE / CTOSD

esq2.jpg (749 bytes)
o
o

CTOSD

A Center for the Treatment of Ocular Surface Disease (CTOSD) has been established under the directorship of Dr. Edward J. Holland. Dr. Holland and his partner Dr. Michael L. Nordlund have developed the CTOSD in collaboration with the Cincinnati Eye Institute, the Department of Ophthalmology at the University of Cincinnati and the St. Elizabeth Hospital in Edgewood, KY. The mission of the CTOSD is to provide expert clinical care for patients with complicated ocular surface stem cell disorders, to further investigate the pathogenesis of stem cell disease and to develop ever improving therapies. Currently, the CTOSD is focusing on stem cell disease resulting from aniridia, thermal and chemical injuries and inflammatory conditions such as Stevens Johnson Syndrome, ocular cicatricial pemphigoid and atopic keratoconjunctivitis. Patients interested in scheduling an evaluation with Dr. Holland or Dr. Nordlund can contact the CTOSD at the phone number and address listed below.20

The CTOSD is conducting several scientific studies. Current basic science research projects are directed at improving our understanding of the pathogenesis of limbal abnormalities in aniridia and the response of stem cells to chemical and mechanical injuries of the cornea. Several clinical studies are also in progress. One study is aimed at more clearly defining the natural history of aniridia and its manifestations. This study primarily involves reviewing charts of aniridic patients to chronical the development of the manifestations of aniridia. Patients with aniridia can participate by providing copies of their ophthalmic medical records. A second study that will be starting in the near future involves evaluating aniridic limbal tissue with varying stages of keratopathy. Patients undergoing stem cell transplantation will be eligible to participate in this study. Patients interested in participating in these clinical investigations can contact the CTOSD using the contact information below.

Edward J. Holland, MD
Michael L. Nordlund, MD,PhD
Center for the Treatment of Ocular Surface Disease
Cincinnati Eye Institiute
10494 Montgomery Road
Cincinnati, OH 45242
Phone (800) 984-5133
Fax (513) 984-4870


esq3.jpg (741 bytes) o esq4.jpg (735 bytes)

WHAT IS ANIRIDIA? | THE ASSOCIATION | PUBLICATIONS

CONFERENCES | UP TO DATE | LINKS | CONTACT | MAIN PAGE